Article Details
Retrieved on: 2024-10-23 20:06:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights discussions at Advamed’s The Medtech Conference, where leaders from the FDA, Johnson & Johnson, and Abbott Laboratories addressed topics including AI, new laboratory test regulations, and medical device oversight under Regulation (EU) 2017/746.
Article found on: www.medtechdive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here